3573- E2 TD 5/5
tD 5/5 stomach 1/3 and whole and selected endpoint
1/3 6000 whole 5000 ulceration and perforation
TD 5/5 whole kidney and selected endpoint
2300 cGy clinical nephritis
TD 5/5 whole liver and selected end point
3000 and liver failure
TD 5/5 whole small intestine and selected end point
4000 obstruction and perforation/fistula
TD 5/5 for whole spinal cord and selected end point
4700 myelitis necrosis
TD 5/5 whole chiasma and selected end point
5000 cGy blindness
TD 5/5 of breast and selected end point
5000, atrophy and necrosis
TD 5/5 whole femoral head and selected end point
5200 cGy necrosis
TD 5/5 skin and selected end point
5500 necrosis and ulceration
TD 5/5 for whole bladder and selected end point
6500 cGy symptomatic bladder contracture and volume loss
TD 50/5
TD 50/5 - tolerance dose for 50% of pop to experience selected end point within 5 years
TD 5/5
tolerance dose for 5 % of pop will experience selected end point within 5 years - used most frequently
td 5/5 1/3 2/3 whole lung and selected end point
1/3 4500 2/3 3000 whole 1750 pneumonitis
TD 5/5 for 1/3 2/3 and whole brain and selected endpoint
1/3 6000 2/3 5000 whole 4500 necrosis and infarction
TD 5/5 for 1/3 2/3 and whole brain stem and selected endpoint
1/3 6000 2/3 5300 whole 5000 necrosis infarction
TD 5/5 1/3 and whole heart and selected end point
1/3 6000 whole 4000 pericarditis
TD 5/5 1/3 and whole esophagus and selected endpoint
1/3 6000 whole 5500 clinical stricture/perforation
TD 5/5 of whole uterus and endpoint
10,000 necrosis , perforat
TD 5/5 whole eye lens and selected endpoint
1000 cataracts requiring intervention
whole Parotid TD 5/5 and selected endpoint
3200 xerostomia
TD 5/5 whole colon and selected end point
4500 obstruction/ perforation
TD 5/5 whole optic nerve and selected endpoint
5000 blindness
TD 5/5 for oral cavity
6000 ulceration
TD 5/5 whole rectum and selected end point
6000 severe proctitis / necrosis / fistula, stenosis
TD 5/5 whole larynx and selected end point
7000 cartilage necrosis
